Information
Code | FAR521 |
Name | Cardiovascular Drugs I |
Term | 2024-2025 Academic Year |
Semester | . Semester |
Duration (T+A) | 2-0 (T-A) (17 Week) |
ECTS | 4 ECTS |
National Credit | 2 National Credit |
Teaching Language | Türkçe |
Level | Yüksek Lisans Dersi |
Type | Normal |
Mode of study | Yüz Yüze Öğretim |
Catalog Information Coordinator | Prof. Dr. NURAN ÖĞÜLENER |
Course Goal / Objective
Proposed to provide to explain the effects, mechanisms of action, side effects, contraindications, interactions and clinical pharmacology of drugs used in the treatment of cardiovascular diseases.
Course Content
Fundamentals of physiopathology of cardiovascular diseases, physiological and pharmacological properties of drugs affecting this system, mechanisms of action, side effects, contraindications and drug interactions
Course Precondition
None
Resources
Basic & Clinical Pharmacology, McGraw-Hill Medical Books, 2018 Goodman and Gilman's The Pharmacologi-cal Basis of Therapeutics-13 th Edition, McGraw-Hill Medical Books, 2018 Lippincott's Illustrated Reviews: Pharmacology,Lippincott Williams & Wilkins, 2018
Notes
https://go.drugbank.com/
Course Learning Outcomes
Order | Course Learning Outcomes |
---|---|
LO01 | Defines the physiopathology of cardiovascular diseases. |
LO02 | Classifies drugs effective on cardiovascular system. |
LO03 | Classify the antihypertensive drugs. |
LO04 | Explain the antihypertensive effect mechanism of antihypertensive drugs, their use, side effects, contrandications and interactions. |
LO05 | Classifiy the drugs used in peripheral vascular diseases and explain and compare the pharmacokinetics, pharmacodynamics and mechanism of action, side effects, contraindications and interactions of the drugs used. |
Relation with Program Learning Outcome
Order | Type | Program Learning Outcomes | Level |
---|---|---|---|
PLO01 | Bilgi - Kuramsal, Olgusal | Ability to use the concepts of pharmacology, pharmacokinetics and pharmacodynamics | 3 |
PLO02 | Bilgi - Kuramsal, Olgusal | Establishes relationships between drug effects, mechanisms of action, and drug interactions | 4 |
PLO03 | Bilgi - Kuramsal, Olgusal | Explains the side effects and toxic effects of drugs | 3 |
PLO04 | Yetkinlikler - Alana Özgü Yetkinlik | Uses an experimental setup for an in vitro or in vivo pharmacological study | |
PLO05 | Bilgi - Kuramsal, Olgusal | Follows scientific literature related to his/her field | 3 |
PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Takes part in the design, maintenance and analysis of data of a research related to his/her field. | |
PLO07 | Bilgi - Kuramsal, Olgusal | Is aware of the importance of scientific research ethics. | |
PLO08 | Beceriler - Bilişsel, Uygulamalı | Expresses scientific thought analytically and establishes hypotheses. | |
PLO09 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Takes part in the statistical evaluation of data. | |
PLO10 | Beceriler - Bilişsel, Uygulamalı | Aware of the importance of rational drug use | 3 |
Week Plan
Week | Topic | Preparation | Methods |
---|---|---|---|
1 | Introduction to Cardiovascular System Drugs | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
2 | Diagnosis, pathogenesis and treatment guidelines for hypertension | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
3 | Classification of Antihypertensive Drugs | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
4 | Mechanisms of Action and classification of diuretics | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası, Soru-Cevap |
5 | Diuretic drugs and their pharmacological effects | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası, Soru-Cevap |
6 | Angiotensin-Converting Enzyme Inhibitors | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
7 | Angiotensin Receptor Blockers and Renin Inhibitors | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
8 | Mid-Term Exam | Should be study to textbooks and presentations | Ölçme Yöntemleri: Yazılı Sınav |
9 | Classification of Calcium Channel Blockers, Effects and Mechanisms of Action | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Tartışma, Beyin Fırtınası |
10 | Side Effects, Contraindications, Interactions and Therapeutic Uses of Calcium Channel Blockers | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
11 | Beta Adrenergic Receptor Blockers I | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
12 | Beta Adrenergic Receptor Blockers II | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap |
13 | Drugs Used in Peripheral Vascular Diseases I | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap |
14 | Drugs Used in Peripheral Vascular Diseases II | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Beyin Fırtınası |
15 | General review | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma, Beyin Fırtınası |
16 | Term Exams | Should study presentations and textbooks | Ölçme Yöntemleri: Yazılı Sınav |
17 | Term Exams | Should study presentations and textbooks | Ölçme Yöntemleri: Yazılı Sınav |
Student Workload - ECTS
Works | Number | Time (Hour) | Workload (Hour) |
---|---|---|---|
Course Related Works | |||
Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
Out of Class Study (Preliminary Work, Practice) | 14 | 4 | 56 |
Assesment Related Works | |||
Homeworks, Projects, Others | 0 | 0 | 0 |
Mid-term Exams (Written, Oral, etc.) | 1 | 8 | 8 |
Final Exam | 1 | 12 | 12 |
Total Workload (Hour) | 104 | ||
Total Workload / 25 (h) | 4,16 | ||
ECTS | 4 ECTS |